BCJ Capital Management »

Arcutis Biotherapeutics shares owned by BCJ Capital Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by BCJ Capital Management from 13F filings

Historical chart of BCJ Capital Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by BCJ Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by BCJ Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $540k 19k 29.04
2025-06-30 $350k 25k 14.02

More positions owned by BCJ Capital Management

Select Sector Spdr Tr State Street Tec (XLK)
Ishares Core Msci Emkt (IEMG)
Select Sector Spdr Tr State Street Fin (XLF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Univrsl Usd (IUSB)
Alphabet Cap Stk Cl C (GOOG)
Select Sector Spdr Tr State Street Hea (XLV)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Apple (AAPL)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Select Sector Spdr Tr State Street Com (XLC)
Ishares Tr Core S&p Us Vlu (IUSV)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for BCJ Capital Management

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Jennison Associates
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
UBS Group
Geode Capital Management
Henderson Group
D. E. Shaw & Co
Ensign Peak Advisors
Franklin Resources

View all funds holding Arcutis Biotherapeutics